Year in review 2014: Interstitial lung disease, physiology, sleep and ventilation, acute respiratory distress syndrome, cystic fibrosis, bronchiectasis and rare lung disease-Reference-Cited by-同舟云学术

Year in review 2014: Interstitial lung disease, physiology, sleep and ventilation, acute respiratory distress syndrome, cystic fibrosis, bronchiectasis and rare lung disease

Published:2015-03-30 Issue:5 Volume:20 Page:834-845
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Maher Toby M.¹²,Piper Amanda³⁴,Song Yuanlin⁵,Restrepo Marcos I.⁶,Eves Neil D.⁷

Affiliation:

1. National Institute for Health Research Respiratory Biomedical Research Unit; Royal Brompton Hospital; London UK

2. Fibrosis Research Group; Centre for Leukocyte Biology; National Heart Lung Institute; Imperial College; London UK

3. Department of Respiratory and Sleep Medicine; Royal Prince Alfred Hospital; Sydney New South Wales Australia

4. Circadian Group; Woolcock Institute of Medical Research; University of Sydney; Sydney New South Wales Australia

5. Department of Pulmonary Medicine; Zhongshan Hospital, and Qingpu Branch; Fudan University; Shanghai China

6. South Texas Veterans Health Care System; University of Texas Health Science Center; San Antonio Texas USA

7. Centre for Heart, Lung and Vascular Health; School of Health and Exercise Sciences; Faculty of Health and Social Development; University of British Columbia; Kelowna British Columbia Canada

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.12532/fullpdf

Reference117 articles.

1. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis;Richeldi;N. Engl. J. Med.,2014

2. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis;King;N. Engl. J. Med.,2014

3. The treatment of idiopathic pulmonary fibrosis;Woodcock;F1000Prime Rep.,2014

4. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials;Noble;Lancet,2011

5. Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis;Valeyre;Respirology,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Year in review 2016: Interstitial lung disease, pulmonary vascular disease, pulmonary function, paediatric lung disease, cystic fibrosis and sleep;Respirology;2017-05-25

2. Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease;Respirology;2016-02-24